752
Views
2
CrossRef citations to date
0
Altmetric
Editorial

Hepatic inflammation resulting from localized, subcutaneous expression of Parvovirus VP1u capsid protein: Importance and implication

&
Pages 70-71 | Received 06 Jan 2016, Accepted 06 Jan 2016, Published online: 08 Feb 2016

References

  • Hsu TC, Chiu CC, Chang SC, Chan HC, Shi YF, Chen TY, Tzang BS. Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice. Virulence 2015; 7(2); PMID:26632342; http://dx.doi.org/10.1080/21505594
  • Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004; 350:586-596; PMID:14762186; http://dx.doi.org/10.1056/NEJMra030840
  • Lehmann HW, von Landenberg P, Modrow S. Parvovirus B19 Infection and autoimmune disease. Autoimmunity Review 2003; 2(4): 218-223; http://dx.doi.org/10.1016/S1568-9972(03)00014-4
  • Adamson-Small LA, Ignatovich IV, Laemmerhirt MG, Hobbs JA. Persistent parvovirus B19 infection in non-erythroid tissues: possible role in the inflammatory and disease process. Virus Res 2014; 190:8-16; PMID:24998884; http://dx.doi.org/10.1016/j.virusres.2014.06.017
  • Berns KI, Bergoin M, Bloom M, Lederman M, Muzyczka N, Siegl G, Tal J, Tattersall P. Family Parvoviridae. In: Regenmortel MHV, Fauquet CM, Bishop DHL, et al., editors. Virus taxonomy: classification and nomenclature of viruses: seventh report of the International Committee on Taxonomy of Viruses. New York: Academic Press; 2000. p. 169-78.
  • Agbandje M, Kajigaya S, McKenna R, Young NS, Rossmann MG. The structure of human parvovirus B19 at 8 Å resolution. Virology 1994; 203:106-15.; PMID:8030266; http://dx.doi.org/10.1006/viro.1994.1460
  • Moffatt S, Tanaka N, Tada K, Nose M, Nakamura M, Muraoka O, Hirano T, Sugamura K. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol 1996; 70(12): 8485-91; PMID:8970971
  • Fu Y, Ishii KK, Munakata Y, Saitoh T, Kaku M, Sasaki T. Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2. J Virol 2002; 76(11): 5395-403; PMID:11991968; http://dx.doi.org/10.1128/JVI.76.11.5395-5403.2002
  • Hsu TC, Tzang BS, Huang CN, Lee YJ, Liu GY, Chen MC, Tsay GJ. Increased expression and secretion of interleukin-6 in human parvovirus B19 non-structural protein (NS1) transfected COS-7 epithelial cells. Clin Exp Immunol 2006; 144(1): 152-7; PMID:16542377; http://dx.doi.org/10.1111/j.1365-2249.2006.03023.x
  • Duechting A, Tschöpe C, Kaiser H, Lamkemeyer T, Tanaka N, Aberle S, Lang F, Torresi J, Kandolf R, Bock CT. Human parvovirus B19 NS1 protein modulates inflammatory signaling by activation of STAT3/PIAS3 in human endothelial cells. J Virol 2008; 82(16): 7942-52; PMID:18550668; http://dx.doi.org/10.1128/JVI.00891-08
  • Dorsch S, Liebisch G, Kaufmann B, von Landenberg P, Hoffmann JH, Drobnik W, Modrow S. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol 2002; 76(4): 2014-8.; PMID:11799199; http://dx.doi.org/10.1128/JVI.76.4.2014-2018.2002
  • Deng X, Dong Y, Yi Q, Huang Y, Zhao D, Yang Y, Tijssen P, Qiu J, Liu K, Li Y. The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells. PLoS One 2013; 8(4): e61440
  • Takahashi Y, Murai C, Shibata S, Munakata Y, Ishii T, Ishii K, Saitoh T, Sawai T, Sugamura K, Sasaki T. Human parvovirus B19 as a causative agent for rheumatoid arthritis. PNAS 1998; 95(14): 8227-32; PMID:9653169; http://dx.doi.org/10.1073/pnas.95.14.8227
  • Isa A, Lundqvist A, Lindblom A, Tolfvenstam A, Broliden K. Cytokine responses in acute and persistent human parvovirus B19 infection. Clin Exp Immunol 2007; 147(3): 419-425; PMID:17302890; http://dx.doi.org/10.1111/j.1365-2249.2006.03286.x
  • Wang JH, Zhang WP, Liu HX, Wang D, Li YF, Wang WQ, Wang L, He FR, Wang Z, Yan QG, Chen LW, Huang GS. Detection of human parvovirus B19 in papillary thyroid carcinoma. Br J Cancer 2008; 98(3): 611-8; PMID:18212749; http://dx.doi.org/10.1038/sj.bjc.6604196
  • Heegaard ED, Brown KE. Human Parvovirus B19. Clin Microbiol Rev 2002; 15(3): 485-505; PMID:12097253; http://dx.doi.org/10.1128/CMR.15.3.485-505.2002
  • Tsai CC1, Tzang BS, Chiang SY, Hsu GJ, Hsu TC. Increased expression of Matrix Metalloproteinase 9 in liver from NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein. J Biomed Scie 2009; 16:14; http://dx.doi.org/10.1186/1423-0127-16-14
  • Tzang BS, Lin TM, Tsai CC, Hsu JD, Yang LC, Hsu TC. Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein. Mol Immunol 2001; 48(12-13):1518-24.
  • Hsu TC, Tsai CC, Chiu CC, Hsu JD, Tzang BS. Exacerbating Effects of Human Parvovirus B19 NS1 on Liver Fibrosis in NZB/W F1 Mice. PLoS ONE 2013; 9(1): 10.1371.
  • Kerr JR, Barah F, Mattey DL, Laing I, Hopkins SJ, Hutchinson IV, Tyrrell DA. Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue. J Gen Virol 2001; 82: 3011-9; PMID:11714978; http://dx.doi.org/10.1099/0022-1317-82-12-3011
  • Moffatt S, Tanaka N, Tada K, Nose M, Nakamura M, Muraoka O, Hirano T, Sugamura K. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol 1996; 70(12): 8485-91; PMID:8970971
  • Li Y, Wang J, Zhu G, Zhang X, Zhai H, Zhang W, Wang W, Huang G. Detection of parvovirus B19 nucleic acids and expression of viral VP1/VP2 antigen in human colon carcinoma. Am J Gastroenterol 2007; 102(7): 1489-98; PMID:17459020; http://dx.doi.org/10.1111/j.1572-0241.2007.01240.x